Detection of ERBB2amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays

MLA

Robinson, Carrie L., et al. “Detection of ERBB2amplification in Uterine Serous Carcinoma by Next-Generation Sequencing: An Approach Highly Concordant with Standard Assays.” Modern Pathology, vol. 34, no. 3, Mar. 2021, pp. 603–12. EBSCOhost, https://doi.org/10.1038/s41379-020-00695-5.

APA

Robinson, C. L., Harrison, B. T., Ligon, A. H., Dong, F., Maffeis, V., Matulonis, U., Nucci, M. R., & Kolin, D. L. (2021). Detection of ERBB2amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays. Modern Pathology, 34(3), 603–612. https://doi.org/10.1038/s41379-020-00695-5

Chicago

Robinson, Carrie L., Beth T. Harrison, Azra H. Ligon, Fei Dong, Valeria Maffeis, Ursula Matulonis, Marisa R. Nucci, and David L. Kolin. 2021. “Detection of ERBB2amplification in Uterine Serous Carcinoma by Next-Generation Sequencing: An Approach Highly Concordant with Standard Assays.” Modern Pathology 34 (3): 603–12. doi:10.1038/s41379-020-00695-5.